A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Clinical trial NCT07599670 · RECRUITING
Trial details
- NCT number
- NCT07599670
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2030-04-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.